sameAs
Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in MexicoAbsolute humidity and the seasonal onset of influenza in the continental United StatesInterference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniaeIntranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococciLittle evidence for genetic susceptibility to influenza A (H5N1) from family clustering dataManaging and reducing uncertainty in an emerging influenza pandemicTransmission dynamics and control of severe acute respiratory syndromePublic health interventions and epidemic intensity during the 1918 influenza pandemicEffect of human leukocyte antigen heterozygosity on infectious disease outcome: the need for allele-specific measuresWeather-based prediction of Plasmodium falciparum malaria in epidemic-prone regions of Ethiopia I. Patterns of lagged weather effects reflect biological mechanismsWeather-based prediction of Plasmodium falciparum malaria in epidemic-prone regions of Ethiopia II. Weather-based prediction systems perform comparably to early detection systems in identifying times for interventionsAre anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivoPandemic influenza: risk of multiple introductions and the need to prepare for them.How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during OutbreaksOrigin and proliferation of multiple-drug resistance in bacterial pathogensHedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapyExploring the relationship between incidence and the average age of infection during seasonal epidemicsTransmissibility of 1918 pandemic influenzaImproving pandemic influenza risk assessment.Antiviral resistance and the control of pandemic influenzaThe severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysisPneumococcal capsular polysaccharide structure predicts serotype prevalenceTargeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistanceEnhancing disease surveillance with novel data streams: challenges and opportunitiesPatient sharing and population genetic structure of methicillin-resistant Staphylococcus aureusThe prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, KenyaShortcomings of vitamin D-based model simulations of seasonal influenzaGenomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013Vaccine testing for emerging infections: the case for individual randomisationViral factors in influenza pandemic risk assessment.The US 2009 A(H1N1) influenza epidemic: quantifying the impact of school openings on the reproductive number.Ethical alternatives to experiments with novel potential pandemic pathogens.The association of meningococcal disease with influenza in the United States, 1989-2009.Inference of seasonal and pandemic influenza transmission dynamics.On the relative role of different age groups in influenza epidemicsReproductive numbers, epidemic spread and control in a community of households.The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.Calls for caution in genome engineering should be a model for similar dialogue on pandemic pathogen research.
P50
Q21142768-8E1CEE76-B8A5-410E-819B-C430104DF508Q21563528-C3DA0D78-FFF0-41F8-AC70-AD993BAE7748Q24548650-06578930-8091-479C-94EB-8DA70831C69AQ24548662-D7EEB6C5-37C3-42CF-8602-B32758B3BD39Q24603728-F3263AAC-7C97-45B9-ADE6-0FB9C884781DQ24630627-2CAD70FE-0DCE-4A0C-8198-7E0DC7BAB8FFQ24654906-B723C35E-2D10-4494-94F5-71E9F0AB17F8Q24670071-3DF65038-CB60-4011-8820-3CFB3D57427BQ24798326-E94B01EE-2B2E-445C-B576-043779DE2C77Q24801618-3D08A0F1-927D-4FF8-AEE5-B019422846E3Q24801655-2C4E512F-0B5C-4219-BA0B-4F098FED5086Q24809188-09FE78A3-B3E9-4C0D-8E98-586ECF002DE8Q25255777-B38A8CC1-B221-42D2-901F-365328C4186FQ25255931-1DDC67EE-4547-44DB-B680-FC5F6DFDB1BDQ26748155-E10F07E7-19C7-42F1-953E-86B8B4E30F6FQ26800248-81DD2D0F-3741-42FC-B032-EB50EB334AE6Q27023284-89EEC571-9251-4D63-B87C-5734134A5F72Q27307203-B6FFDA57-073C-4AD9-AC93-79B6EE05C32BQ27489629-E1225BFE-AE36-4D4C-BDBA-6EC69C0FD090Q28298620-39E15E80-CAE5-4E4E-8273-1DF92B549350Q28395976-58739302-7C27-406B-A04F-31A28FD3001CQ28469119-4C959625-5A2C-43FF-8CDC-8CE14C7A9A41Q28472166-26F417C0-2A65-49A8-A2CF-9E6CFD6FF38FQ28475595-71D36EC3-A071-4590-A085-C413628FE148Q28534880-933F4A3D-41A9-49B9-8B04-B01025A0BF0BQ28587206-398B14A5-A6A9-4230-8750-668A587CEB65Q28730225-6F4D097D-7897-4476-AC9D-2DF406D98D3CQ28731923-80AA5B0F-31FA-47D3-BF8D-576C67D7D088Q28743927-032EBE8B-AAF2-40C8-AF0B-19B200974A12Q28914762-15993767-DF1E-4C5B-B41C-8247D756C962Q29451722-350227F0-B4A2-4099-8904-9E971B29A5AEQ30275435-A31D8C39-1518-4E23-984E-E41899219964Q30357990-72FCCB03-ACDA-43C1-9BF1-D6929D0B3666Q30362738-681F8240-F252-471B-BDD0-782E884F9152Q30367269-3631BAC6-6076-439C-8F3C-6429928D03A7Q30372317-6C323B3F-3404-4620-8C20-F3378126E261Q30375953-7813B702-3122-46BC-B186-E7A6B2432E7EQ30378453-7D71C276-D3F2-4353-99A7-AC59F7907DA9Q30378554-9413707C-8F79-4A8F-A1DA-BA12F7014109Q30378844-BE3056E6-F116-4594-91E6-C292D3572EC9
P50
description
epidemiologist in the United States
@en
epidemioloog in het Verenigde Staten
@nl
հետազոտող
@hy
name
Marc Lipsitch
@ast
Marc Lipsitch
@en
Marc Lipsitch
@es
Marc Lipsitch
@it
Marc Lipsitch
@nl
Marc Lipsitch
@sl
type
label
Marc Lipsitch
@ast
Marc Lipsitch
@en
Marc Lipsitch
@es
Marc Lipsitch
@it
Marc Lipsitch
@nl
Marc Lipsitch
@sl
altLabel
Lipsitch M
@en
M. Lipsitch
@en
prefLabel
Marc Lipsitch
@ast
Marc Lipsitch
@en
Marc Lipsitch
@es
Marc Lipsitch
@it
Marc Lipsitch
@nl
Marc Lipsitch
@sl
P2671
P106
P1412
P1556
lipsitch.marc
P1960
cBEV4DcAAAAJ
P2002
P21
P2671
/g/11c73jrhv6
P31
P496
0000-0003-1504-9213
P569
2000-01-01T00:00:00Z